These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8773948

  • 1. Synthesis, biodistribution, and estrogen receptor scintigraphy of indium-111-diethylenetriaminepentaacetic acid-tamoxifen analogue.
    Delpassand ES, Yang DJ, Wallace S, Cherif A, Quadri SM, Price J, Joubert A, Inoue T, Podoloff DA.
    J Pharm Sci; 1996 Jun; 85(6):553-9. PubMed ID: 8773948
    [Abstract] [Full Text] [Related]

  • 2. Imaging, biodistribution and therapy potential of halogenated tamoxifen analogues.
    Yang DJ, Li C, Kuang LR, Price JE, Buzdar AU, Tansey W, Cherif A, Gretzer M, Kim EE, Wallace S.
    Life Sci; 1994 Jun; 55(1):53-67. PubMed ID: 8015349
    [Abstract] [Full Text] [Related]

  • 3. Biodistribution and scintigraphy of [111In]DTPA-adriamycin in mammary tumor-bearing rats.
    Higuchi T, Yang DJ, Ilgan S, Tansey LW, Zareneyrizi F, Inoue T, Endo K, Kim EE, Podoloff DA.
    Anticancer Drugs; 1999 Jan; 10(1):89-95. PubMed ID: 10194551
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, biodistribution and imaging properties of indium-111-DTPA-paclitaxel in mice bearing mammary tumors.
    Li C, Yu DF, Inoue T, Yang DJ, Tansey W, Liu CW, Milas L, Hunter NR, Kim EE, Wallace S.
    J Nucl Med; 1997 Jul; 38(7):1042-7. PubMed ID: 9225788
    [Abstract] [Full Text] [Related]

  • 5. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC.
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [Abstract] [Full Text] [Related]

  • 6. Biological activities of tamoxifen aziridine, an antiestrogen-based affinity label for the estrogen receptor, in vivo and in vitro.
    Wei LL, Mangel WF, Katzenellenbogen BS.
    J Steroid Biochem; 1985 Dec; 23(6A):875-81. PubMed ID: 3937947
    [Abstract] [Full Text] [Related]

  • 7. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC, O'Regan RM, Gajdos C, Robinson SP, Bentrem D, De Los Reyes A, Jordan VC.
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [Abstract] [Full Text] [Related]

  • 8. Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical.
    Wang S, Luo J, Lantrip DA, Waters DJ, Mathias CJ, Green MA, Fuchs PL, Low PS.
    Bioconjug Chem; 1997 Jun; 8(5):673-9. PubMed ID: 9327130
    [Abstract] [Full Text] [Related]

  • 9. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
    Gottardis MM, Robinson SP, Satyaswaroop PG, Jordan VC.
    Cancer Res; 1988 Feb 15; 48(4):812-5. PubMed ID: 3338079
    [Abstract] [Full Text] [Related]

  • 10. Estrogen-like effects of tamoxifen on human endometrial carcinoma transplanted into nude mice.
    Satyaswaroop PG, Zaino RJ, Mortel R.
    Cancer Res; 1984 Sep 15; 44(9):4006-10. PubMed ID: 6744316
    [Abstract] [Full Text] [Related]

  • 11. Imaging tumor folate receptors using 111In-DTPA-methotrexate.
    Ilgan S, Yang DJ, Higuchi T, Zareneyrizi F, Kim EE, Podoloff DA.
    Cancer Biother Radiopharm; 1998 Jun 15; 13(3):177-84. PubMed ID: 10850353
    [Abstract] [Full Text] [Related]

  • 12. Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic mice.
    Schafer JM, Lee ES, O'Regan RM, Yao K, Jordan VC.
    Clin Cancer Res; 2000 Nov 15; 6(11):4373-80. PubMed ID: 11106256
    [Abstract] [Full Text] [Related]

  • 13. Differential ability of antiestrogens to stimulate breast cancer cell (MCF-7) growth in vivo and in vitro.
    Gottardis MM, Wagner RJ, Borden EC, Jordan VC.
    Cancer Res; 1989 Sep 01; 49(17):4765-9. PubMed ID: 2758410
    [Abstract] [Full Text] [Related]

  • 14. [Influence of endocrine therapy on the proliferation of estrogen (ER) positive cells and ER negative cells of human breast cancer (MCF-7)].
    Noguchi M, Tajiri K, Taniya T, Kumaki T, Miyazaki I.
    Nihon Geka Gakkai Zasshi; 1989 May 01; 90(5):780-5. PubMed ID: 2529423
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of [18F]fluoroalanine and [18F]fluorotamoxifen for imaging breast tumors.
    Yang D, Kuang LR, Cherif A, Tansey W, Li C, Lin WJ, Liu CW, Kim EE, Wallace S.
    J Drug Target; 1993 May 01; 1(3):259-67. PubMed ID: 8069568
    [Abstract] [Full Text] [Related]

  • 16. Estrogen inhibits the growth of estrogen receptor-negative, but not estrogen receptor-positive, human mammary epithelial cells expressing a recombinant estrogen receptor.
    Zajchowski DA, Sager R, Webster L.
    Cancer Res; 1993 Oct 15; 53(20):5004-11. PubMed ID: 8402691
    [Abstract] [Full Text] [Related]

  • 17. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL, Sugimoto Y, Liu S, Ye W, Wang LS, Huang YW, Lin YC.
    Anticancer Res; 2006 Oct 15; 26(3A):1773-84. PubMed ID: 16827106
    [Abstract] [Full Text] [Related]

  • 18. Reversal of tamoxifen resistant breast cancer by low dose estrogen therapy.
    Osipo C, Gajdos C, Cheng D, Jordan VC.
    J Steroid Biochem Mol Biol; 2005 Feb 15; 93(2-5):249-56. PubMed ID: 15860267
    [Abstract] [Full Text] [Related]

  • 19. TAT-59, a new triphenylethylene derivative with antitumor activity against hormone-dependent tumors.
    Toko T, Sugimoto Y, Matsuo K, Yamasaki R, Takeda S, Wierzba K, Asao T, Yamada Y.
    Eur J Cancer; 1990 Mar 15; 26(3):397-404. PubMed ID: 2141500
    [Abstract] [Full Text] [Related]

  • 20. Pharmacodynamics of tamoxifen and its 4-hydroxy and N-desmethyl metabolites: activation of caspases and induction of apoptosis in rat mammary tumors and in human breast cancer cell lines.
    Mandlekar S, Hebbar V, Christov K, Kong AN.
    Cancer Res; 2000 Dec 01; 60(23):6601-6. PubMed ID: 11118041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.